Mesenchymal stem cell expressing TRAIL as targeted therapy against sensitised tumour
Tapping into the ability of engineered mesenchymal stem cells (MSCs) to mobilise into the tumour has expanded the scope of cancer treatment. Engineered MSCs expressing tumour necrosis factor (TNF)-related apoptosis inducing ligand (MSC-TRAIL) could serve as a platform for an efficient and targeted f...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Статья |
| Язык: | English |
| Опубликовано: |
MDPI
2018
|
| Online-ссылка: | http://psasir.upm.edu.my/id/eprint/74939/1/ijms-19-02188.pdf |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|
Ваш комментарий будет первым!